+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Rx/Reimbursement Adult Incontinence in Croatia

  • PDF Icon

    Report

  • 17 Pages
  • March 2024
  • Region: Croatia
  • Euromonitor International
  • ID: 4764620
As with retail adult incontinence, an ageing population remained the key driver of Rx/reimbursement sales in Croatia in 2023, with the category recording solid volume and current value growth in the year. Incontinence products are considered medical products under Croatian law and are subsidised by health insurance companies if prescribed by doctors, so price plays an important role in demand. However, many older consumers remain reticent about the condition due to the taboo associated with it.

The Rx/Reimbursement adult incontinence in Croatia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2028 illustrate how the market is set to change.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Rx/Reimbursement adult incontinence market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

RX/REIMBURSEMENT ADULT INCONTINENCE IN CROATIAKEY DATA FINDINGS
2023 DEVELOPMENTS
  • An ageing population remains the key driver of Rx/reimbursement sales in 2023
  • Rx/reimbursement adult incontinence limited to moderate/heavy products
  • Treatment delay further supports category
PROSPECTS AND OPPORTUNITIES
  • Further growth supported by an ageing population and improving awareness of the condition
  • Growth to slow with a rising focus on prevention over cure
  • Innovation to improve absorbency and comfort
CATEGORY DATA
  • Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2018-2023
  • Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2018-2023
  • Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2023-2028
  • Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2023-2028
TISSUE AND HYGIENE IN CROATIA
EXECUTIVE SUMMARY
  • Tissue and hygiene in 2023: The big picture
  • 2023 key trends
  • Competitive landscape
  • Retailing developments
  • What next for tissue and hygiene?
MARKET INDICATORS
  • Table 5 Birth Rates 2018-2023
  • Table 6 Infant Population 2018-2023
  • Table 7 Female Population by Age 2018-2023
  • Table 8 Total Population by Age 2018-2023
  • Table 9 Households 2018-2023
  • Table 10 Forecast Infant Population 2023-2028
  • Table 11 Forecast Female Population by Age 2023-2028
  • Table 12 Forecast Total Population by Age 2023-2028
  • Table 13 Forecast Households 2023-2028
MARKET DATA
  • Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2018-2023
  • Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2018-2023
  • Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2019-2023
  • Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2020-2023
  • Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2018-2023
  • Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2018-2023
  • Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2023
  • Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2023-2028
  • Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2023-2028
DISCLAIMER
SOURCES
  • Summary 1 Research Sources